IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

Published on Jun 24
54:07
Hematologic Oncology Update
0:00
0:00
<p>Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.&nbsp;&nbsp;</p><p>CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayIDHMutantGlioma24" rel="noopener noreferrer" target="_blank">here</a>. </p>